about
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapyMultiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsEpigenetic alterations of the Wnt signaling pathway in cancer: a mini reviewStructural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoniSelective inhibition of tumor oncogenes by disruption of super-enhancersHistone acetyltransferase inhibitors block neuroblastoma cell growth in vivoModulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294.RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair.Rapid epigenetic adaptation to uncontrolled heterochromatin spreading.Altering cancer transcriptomes using epigenomic inhibitorsDisubstituted naphthyl β-D-xylopyranosides: Synthesis, GAG priming, and histone acetyltransferase (HAT) inhibition.Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.Subsets of Visceral Adipose Tissue Nuclei with Distinct Levels of 5-Hydroxymethylcytosine.Generalized nucleation and looping model for epigenetic memory of histone modifications.Targeting epigenetic regulators for cancer therapy.Emerging drugs for diffuse large B-cell lymphoma.Epigenetic therapy for solid tumors: from bench science to clinical trials.Opportunities and challenges provided by crosstalk between signalling pathways in cancer.Entinostat (SNDX-275) for the treatment of non-small cell lung cancer.Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer.The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.Cancer epigenetics: new therapies and new challenges.MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development.Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer.A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity.Epigenetik in der OnkologieEnvironmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics
P2860
Q24609974-E0B2002E-4DCD-483B-B329-2DA0BDDDD3FAQ26795735-BF281952-BCC2-4E84-B194-C8E7ADF1D130Q26824835-50C6062E-051A-476F-8EDD-DCF53658AE8FQ27680126-DE5C224B-F875-438E-8048-D0B3BA8E9F53Q29617301-9F5EB564-FCF5-430B-8A29-85CC2BAFCF81Q30316789-49401A55-F33C-48A5-BA89-C94164C9721AQ33727680-20FF6C3E-B3FA-4863-AABA-603F61EE5A9AQ34513042-0B8EE477-02F6-4921-A612-40685F3219F0Q34674423-6C1A097C-1F99-4377-9A3F-AF9552761B2AQ35400929-DA2BD49A-35C5-496B-9F05-398442DD5D98Q35863203-20EFED4C-A39F-479A-93AA-220E15730EE1Q35973008-3EA409A5-7555-4559-A897-5ECC2BFE173DQ36040449-BCCDC6C8-BE4D-49BE-949F-9946B1B84F02Q36584337-E3D14F3E-123D-49CF-952C-2A916587A0E0Q36896396-3995A002-45B7-4A10-AFCC-4841D7AD65F6Q37126598-F29CCC1D-8BB1-4BD4-823D-C72461C88C94Q38191266-9F486EFF-D989-4669-9BB1-2FD8E14948CCQ38344404-56830BD9-7D4C-4697-85A6-E9959CF2C23EQ38459836-5C10726F-1534-44BA-BF8A-8EB477089034Q38485894-E309F30D-54FD-46B9-83E8-ADD9A9C9A66AQ38534163-6E0EBDBD-B336-4E11-A202-C673475CA8D1Q38880716-5329A4D5-2D19-438C-A1C2-907B05E1B418Q39041044-F933AF5D-C502-4851-9959-69A4BEBA7D18Q41462661-5CD60817-070D-424A-A20A-1280729EC91BQ43226742-8808CCB3-1DA4-4DD7-99ED-44D6FA18FED3Q47678061-4ABFE2DA-4548-46B7-AF73-13949D6BEA08Q52928162-5F470CE4-D7F4-43D9-9C17-4D54A93202A2Q53067336-0B47B92A-91B8-4AB5-8CB4-0081C300009FQ53069742-9BBE008C-F539-4382-A583-1CB3097489E0Q58034903-78486335-0C2F-42EE-A0B6-5F11803E100EQ58734090-54EA0B83-4C25-43B5-91FC-3DB161076771
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Targeting the epigenome for treatment of cancer.
@en
Targeting the epigenome for treatment of cancer.
@nl
type
label
Targeting the epigenome for treatment of cancer.
@en
Targeting the epigenome for treatment of cancer.
@nl
prefLabel
Targeting the epigenome for treatment of cancer.
@en
Targeting the epigenome for treatment of cancer.
@nl
P2860
P356
P1433
P1476
Targeting the epigenome for treatment of cancer.
@en
P2093
E-J Geutjes
P2860
P2888
P304
P356
10.1038/ONC.2011.552
P407
P577
2011-12-05T00:00:00Z